Table 2

Short-term complications

StudyGore TAGPiffaretti et al26Hughes et al28
Arm (participants)ESG (n=140)OSR (n=94)ESG (n=17)OSR (n=11)ESG (n=712)OSR (n=8255)
Neurological
ParaplegiaNRNRNRNRNRNR
Paraplegia/paraperisis4 (3%)13 (14%)NRNRNRNR
Cerebral vascular accident5 (4%)5 (4%)2 (9%)1 (12%)NRNR
Neurological-unspecified typeNRNRNRNR20 (2.8%)273 (3.3%)
Respiratory
Respiratory failure5 (4%)19 (20%)NRNRNRNR
PneumoniaNRNR2 (12%)3 (27%)NRNR
Pulmonary-unspecified typeNRNRNRNR17 (2.4%)462 (5.6%)
Cardiac
Myocardial Infarction0 (0%)1 (1%)0 (0%)1 (9%)NRNR
Cardiac-unspecified typeNRNRNRNR28 (2.9%)1252 (15.2%)
Endoleaks
Endoleaks12 (8.5%)NRNRNRNRNR
Other
Peripheral vascular disease20 (14%)4 (4%)NRNRNRNR
Renal failure2 (1%)12 (13%)NRNRNRNR
Wound infection/dehiscence5 (4%)10 (11%)NRNRNRNR
Gastrointestinal complication3 (2%)6 (6%)NRNRNRNR
Postimplant syndromeNRNR4 (18%)0 (0%)NRNR
  • Goodney et al25 and von Allmen et al27 did not report short-term complications.

  • ESG, endovascular stent grafting; NR, not reported; OSR, open surgical repair.